| 12/18/2024 | CVLM | MannKind negotiates with holders of 2.5% convertibles on exchange
|
| 3/16/2021 | CV | MannKind greenshoe lifts 2.5% five-year convertibles to $230 million
|
| 3/2/2021 | CV | Market Commentary: Convertibles primary on fire; $3.23 billion in six deals on deck; Twitter below par
|
| 3/2/2021 | CV | Market Commentary: Morning Commentary: Convertibles primary on fire; $3.23 billion in six deals on deck
|
| 3/2/2021 | CV | New Issue: MannKind sells upsized $200 million five-year convertibles to yield 2.5%, up 30%
|
| 3/1/2021 | CV | Market Commentary: Primary markets $4.1 billion convertibles in eight deals; Twitter, Shake Shack eyed
|
| 3/1/2021 | CV | Market Commentary: Morning Commentary: Twitter, Shake Shack, MannKind convertible note offerings eyed
|
| 3/1/2021 | CV | MannKind talks $150 million five-year convertible notes to yield 2.25%-2.75%, up 37.5%-32.5%
|
| 6/11/2018 | CVLMPV | MannKind to issue stock in exchange for $6 million of convertibles
|
| 5/25/2018 | CVLM | MannKind to issue stock in exchange for $5 million 5.75% convertibles
|
| 1/19/2018 | CVLM | MannKind says holders convert $5.59 million of 9.75% notes due 2019
|
| 10/23/2017 | CV | MannKind to defer $10 million on 9.75% notes, exchanges 5.75% notes
|
| 10/23/2017 | CVLM | MannKind to issue 5.75% convertibles due 2021 and stock in exchange
|
| 8/13/2015 | CVLM | MannKind to issue 5.75% subordinated convertibles due 2015 in exchange
|
| 7/29/2015 | CVLM | MannKind to issue new notes, stock for $84.6 million convertibles
|
| 7/25/2014 | CV | Market Commentary: Morning Commentary: Tower Group convertibles get better bid; MannKind stock under pressure
|
| 6/27/2014 | CV | Market Commentary: Convertible primary market quiet after active week; MannKind gets Afrezza drug approval
|
| 4/7/2014 | CV | Market Commentary: Midday Commentary: Convertibles quiet as selling hits stocks; Genco steady just under par
|
| 4/7/2014 | CV | Market Commentary: Convertibles in line to slightly higher on hedge; Tesla, Priceline, Fluidigm in trade
|
| 4/2/2014 | CV | Market Commentary: New McDermott adds; DFC Global sister convertibles surge on buyout news; 51job deal on tap
|
| 3/28/2014 | CV | Market Commentary: Convertibles mostly quiet; HomeAway gains on swap from issue; hedged players lift SanDisk
|
| 3/28/2014 | CV | Market Commentary: Midday Commentary: MannKind quiet ahead of Afrezza regulatory decision; MGM flat to lower outright
|
| 3/21/2014 | CV | Market Commentary: Convertibles quiet; National Health lags dollar neutral; Navistar 'holds in;' Sterlite gains
|
| 11/5/2013 | CV | Market Commentary: Midday Commentary: Endo Health looks better on stock surge; Tesla active ahead of earnings news
|
| 11/5/2013 | CV | Market Commentary: Endo Health jumps on Paladin deal; General Cable, BroadSoft slide outright; deals emerge
|
| 11/4/2013 | CV | Market Commentary: Covanta adds dollar neutral, shares higher; Volcano in line; Tesla active, slightly better
|
| 8/14/2013 | CV | Market Commentary: AMR extends dive after merger opposed; MannKind up on trial data; American Equity slips
|
| 2/11/2013 | CV | Market Commentary: New Molina upsizes; planned Molina, Starwood bid higher in gray; Regeneron 'comes in'
|
| 10/29/2012 | CV | Market Commentary: Convertibles silent: U.S. equity, bond markets shut as Sandy approaches; data delays eyed
|
| 10/18/2012 | CV | Market Commentary: New Walter gains well on debut; Lam Research flat to 'in' slightly on hedge; MannKind down
|
| 8/31/2012 | CVIGPF | MannKind files $500 million shelf covering stock and debt securities
|
| 2/3/2012 | CV | MannKind withdraws planned $161 million convertibles offering
|
| 2/3/2012 | CV | Market Commentary: Gilead adds on hedge on positive drug data; Tyson contracts on hedge; MannKind drops deal
|
| 2/2/2012 | CV | Market Commentary: Central European surges on Russian investment; Electronic Arts, Cemex add after earnings
|
| 2/1/2012 | CV | Market Commentary: BioMarin climbs outright, premium slips; Suntech Power surges; China Medical plunges
|
| 1/31/2012 | CV | MannKind to issue $161 million seven-year convertibles to yield 7%
|
| 1/31/2012 | CV | Market Commentary: RadioShack down on warning; MannKind plans new convertible, existing MannKind paper quiet
|
| 5/27/2011 | CV | Market Commentary: Salesforce ends week slightly better; MannKind trades as shares creep up; Cubist mixed
|
| 1/24/2011 | CV | Market Commentary: Salesforce.com under pressure; RadioShack lower; Molycorp plans mandatory; Nielsen on tap
|
| 1/20/2011 | CV | Market Commentary: Ares Capital, Apollo mostly flat on debuts; Apollo remarketed at 98.5; MannKind plunges
|
| 8/31/2010 | CV | Market Commentary: Saks 'comes in' on hedge amid takeover talk; SanDisk gains, NetApp, Salesforce.com better
|
| 8/19/2010 | CV | New Issue: MannKind prices $100 million five-year convertibles at 5.75%, up 22.5%
|
| 8/19/2010 | CV | Market Commentary: SanDisk slightly higher in the gray; MannKind paper quiet on debut; Intel 2.95% bonds add
|
| 8/18/2010 | CV | Market Commentary: NetApp better; new GM convertible preferred paper eyed; SanDisk launches $1 billion deal
|
| 8/17/2010 | CV | Market Commentary: MannKind quiet in the gray, older MannKind 'marginally better'; Rubbermaid trades actively
|
| 8/16/2010 | CV | MannKind to price $100 million five-year convertible notes to yield 5.25%-5.75%, up 20%-25%
|
| 8/16/2010 | CV | Market Commentary: Convertibles muted; MannKind to price $100 million deal; King Pharma quiet as shares add
|
| 4/30/2010 | CVIG | MannKind files $200 million shelf covering stock and debt securities
|
| 3/15/2010 | CV | Market Commentary: Amylin gains with stock; Knight prices upsized deal at the middle of talk; Group 1 to price
|
| 10/6/2009 | CV | Market Commentary: MannKind drops on partnership deal delay; Medtronic, Transocean gain; Avis, AirTran plan deals
|
| 10/2/2009 | CV | Market Commentary: UAL dips but ends higher on debut; Spansion recovers some; U.S. Steel, BorgWarner soften
|
| 9/22/2009 | CV | Market Commentary: AMR adds in gray, then upsizes; MannKind gains more: Goodrich, ATP, Incyte, Gaylord to price
|
| 9/21/2009 | CV | Market Commentary: AMR launches convertible; Amgen, MannKind, Nektar active in trade; Sonic, Kodak richen
|
| 8/9/2007 | CVIG | MannKind files $350 million shelf
|
| 6/11/2007 | CV | Market Commentary: MannKind takes off; Molson quiet in gray; Human Genome rebounds; three REITs, Trex launch deals
|
| 12/12/2006 | CV | MannKind greenshoe exercised, raising 3.75% convertibles to $115 million
|
| 12/7/2006 | CV | New Issue: MannKind prices $100 million seven-year convertibles richer than talk, at 3.75%, up 29%
|
| 12/7/2006 | CV | Market Commentary: Ford drives market into frenzy; MannKind leaps ahead; Superior Energy flat in gray; Prudential plans deal
|
| 12/6/2006 | CV | Market Commentary: Ford climbs further on upsize, new talk; First Potomac, Acadia flat on debuts; Superior Energy plans deal
|
| 11/28/2006 | CV | Market Commentary: Ventas flat on debut; AGCO higher in gray; MannKind quiet as stock borrow a concern
|
| 11/27/2006 | CV | MannKind to price $100 million seven-year convertibles, talked at 3.75%-4.25%, up 22%-28%
|
| 11/27/2006 | CV | Market Commentary: Ford stalls on financing plans; Scottish Re climbs on liquidity boost; Ventas gains in gray as deal reoffered
|
| 11/2/2006 | BTCV | Mannkind files $500 million shelf registration
|
| 3/11/2004 | CV | New Issue: MannKind raises $50 million from private placement convertible
|
